AppliedVR Patents

Patent portfolio assigned to AppliedVR (verified via public assignee records). Estimated patent count: 3. AppliedVR (LA) FDA De Novo-cleared VR chronic-pain therapeutic RelieVRx. Patents confirmed on company's own patents page (US 11,073,900; US 11,599,186; US D902,205 = 3 listed, page notes portfolio may be larger). Highmark = first commercial payer; VHA = contract; Geisinger/Cleveland Clinic = clinical partners.